Document Detail


Salvage of a congested DIEAP flap with subcutaneous recombinant tissue plasminogen activator treatment.
MedLine Citation:
PMID:  18851936     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombolytic agents are frequently employed in the treatment of thrombosis in combination with early surgical exploration and management. Recombinant tissue plasminogen activator is a second generation thrombolytic agent, which acts specifically at the site of the haemostatic clot with minimal side effects. In this paper, we present a case with venous congestion of the deep inferior epigastric artery perforator (DIEAP) flap, despite a patent anastomosis, in which we achieved a successful outcome with subcutaneous recombinant tissue plasminogen activator treatment.
Authors:
Suhan Ayhan; Safak Uygur; Ismail Kucukoduk; Ayse Sencan
Related Documents :
21980206 - Risk profile of intracranial aneurysms: rupture rate is not constant after formation.
21907356 - Endovascular versus open repair of ruptured descending thoracic aortic aneurysms: a nat...
7568476 - The arterial basis of pharyngeal flaps.
14758206 - Arterial anatomical features of the upper palpebra.
7154186 - Dissolution of cystine calculi by pelviocaliceal irrigation with tromethamine-e.
16820386 - Relationship between carotid intima-media thickness and arterial stiffness in children ...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2008-10-11
Journal Detail:
Title:  Journal of plastic, reconstructive & aesthetic surgery : JPRAS     Volume:  62     ISSN:  1878-0539     ISO Abbreviation:  J Plast Reconstr Aesthet Surg     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2010-01-19     Completed Date:  2010-02-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101264239     Medline TA:  J Plast Reconstr Aesthet Surg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  e453-4     Citation Subset:  IM    
Copyright Information:
(c) 2008 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
Affiliation:
Gazi University, Faculty of Medicine, Department of Plastic, Reconstructive and Aesthetic Surgery, Ankara, Turkey. msayhan@gazi.edu.tr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Breast Neoplasms / pathology,  surgery
Epigastric Arteries*
Female
Fibrinolytic Agents / therapeutic use*
Follow-Up Studies
Graft Survival
Humans
Injections, Subcutaneous
Mammaplasty / adverse effects*,  methods
Mastectomy / methods
Middle Aged
Postoperative Complications / diagnosis,  drug therapy
Rectus Abdominis / blood supply,  transplantation
Risk Assessment
Salvage Therapy
Surgical Flaps / blood supply*
Thrombosis / drug therapy*,  etiology
Tissue Plasminogen Activator / therapeutic use*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Fibrinolytic Agents; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The radial forearm free flap: a review of microsurgical options.
Next Document:  The first intermediate host of Paragonimus westermani in Sri Lanka.